H Saya Selected Research

Acoustic Neuroma (Acoustic Neurinoma)

5/2001

Identification of the cis-acting region in the NF2 gene promoter as a potential target for mutation and methylation-dependent silencing in schwannoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

H Saya Research Topics

Disease

19	Neoplasms (Cancer) 01/2018 - 03/2000
6	Carcinogenesis 01/2017 - 09/2000
2	Breast Neoplasms (Breast Cancer) 01/2017 - 01/2014
2	Stomach Neoplasms (Stomach Cancer) 07/2014 - 07/2013
2	Warts (Wart) 04/2007 - 05/2000
2	Meningioma (Meningiomas) 11/2001 - 09/2000
2	Neurofibromatosis 2 (Neurofibromatosis Type II) 11/2001 - 09/2000
1	Osteosarcoma (Osteogenic Sarcoma) 08/2014
1	Neoplasm Metastasis (Metastasis) 08/2014
1	Choriocarcinoma 02/2013
1	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell) 06/2012
1	Mesothelioma 04/2010
1	Malignant Mesothelioma 04/2010
1	Ovarian Neoplasms (Ovarian Cancer) 01/2006
1	Acoustic Neuroma (Acoustic Neurinoma) 05/2001
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 04/2001
1	Glioma (Gliomas) 01/2001
1	Neurilemmoma (Schwannoma) 09/2000
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 05/2000

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2016 - 03/2000
4	Phosphotransferases (Kinase)IBA 07/2008 - 05/2000
2	Indicators and Reagents (Reagents)IBA 01/2018 - 07/2013
2	Transcription Factors (Transcription Factor)IBA 01/2017 - 10/2001
2	CytokinesIBA 08/2014 - 07/2014
2	Neurofibromin 2 (Merlin)IBA 11/2001 - 09/2000
2	CalpainIBA 11/2001 - 09/2000
1	Cetuximab (Erbitux)FDA Link 01/2018
1	Surface Antigens (Surface Antigen)IBA 01/2018
1	AntibodiesIBA 01/2017
1	Insulin-Like PeptidesIBA 01/2017
1	CrizotinibIBA 01/2016
1	NADPH Oxidases (NAD(P)H oxidase)IBA 07/2014
1	Type I Tumor Necrosis Factor ReceptorsIBA 07/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2014
1	ClaudinsIBA 01/2014
1	Estrogen ReceptorsIBA 01/2014
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2014
1	Protein Isoforms (Isoforms)IBA 10/2013
1	Biomarkers (Surrogate Marker)IBA 07/2013
1	nutlin 3IBA 06/2012
1	Hyaluronic Acid (Hyaluronan)IBA 04/2010
1	OsteopontinIBA 04/2010
1	Oncogene Proteins (Oncogene Protein)IBA 07/2008
1	Peptide Hydrolases (Proteases)FDA Link 04/2007
1	High-Temperature Requirement A Serine Peptidase 2IBA 04/2007
1	PhosphoproteinsIBA 01/2006
1	mu-calpainIBA 11/2001
1	Messenger RNA (mRNA)IBA 05/2001
1	Neurofibromin 1 (Neurofibromin)IBA 04/2001
1	NocodazoleIBA 01/2001
1	Metalloproteases (Metalloproteinases)IBA 09/2000
1	Cysteine Proteases (Cysteine Protease)IBA 09/2000
1	AntigensIBA 09/2000
1	Monoclonal AntibodiesIBA 09/2000
1	EpitopesIBA 09/2000
1	CalciumIBA 09/2000
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 05/2000
1	ZyxinIBA 05/2000
1	beta CateninIBA 05/2000

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2018 - 04/2010
2	Transplantation 08/2014 - 07/2014
1	Therapeutics 03/2000
1	Radiotherapy 03/2000